Last reviewed · How we verify

NCT07063966

Are Developmentally At Risky Babies Environmentally Disadvantaged?

Not yet recruiting Last updated 14 July 2025
What this trial tests

trial in Risky Baby in 52 participants. Not yet recruiting.

Timeline
3 July 2025
Primary endpoint
10 September 2025
10 November 2025

Quick facts

Lead sponsorAbant Izzet Baysal University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment52
Start date3 July 2025
Primary completion10 September 2025
Estimated completion10 November 2025
Sites3 locations across Turkey (Türkiye)

Conditions studied

Sponsor

Abant Izzet Baysal University

Who can join

Adults 7 Months to 18 Months, any sex, with Risky Baby or Motor Development. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study conducted on infants aged between 3 and 11 months revealed a positive relationship between the home environment and developmental outcomes. Similarly, another study found that variability in motor and cognitive development could be better explained by environmental factors and parental knowledge and practices. It has also been shown that the opportunities provided in the home environment of preterm infants may be associated with motor development and sensory processing skills. In the literature, it is generally observed that studies evaluate either term infants or both preterm and term infants together. In the present study, however, infants at developmental risk and typically developing infants will be evaluated separately. The aim of this study is to assess whether infants at developmental risk are disadvantaged in terms of their home environment. The hypotheses of this study are as follows: H1-1: There is a difference in environmental arrangements between typically developing infants and those at developmental risk. H1-2: There is a relationship between home environmental arrangements and motor development. H1-3: There is a relationship between home environmental arrangements and sensory profile.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Abant Izzet Baysal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07063966.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing